Institutional development · Research, innovation and assessment · Switzerland
ETH Zurich reports magnetic microbots that could help clot-dissolving drugs reach target
ETH Zurich has reported work on flow-generating microbots, driven by magnetic fields, that could help medication reach blood clots which restrict flow in vessels.
Why it matters: The ETH Zurich work targets cases where a clot restricts blood flow so much that dissolving medication can barely reach it.
ETH Zurich reported on 9 November 2026 on flow-generating microbots intended for use in dissolving blood clots.
According to ETH Zurich, a clot can restrict blood flow in a vessel so severely that drugs meant to break it down can barely reach it.
The university said microbots driven by magnetic fields could offer an unusual solution to this problem.
Editor’s view
Scott James, Research and Innovation Editor
ETH Zurich presents the magnetically driven microbots as a possible way to get clot-dissolving medication to its target when blood flow is restricted, describing the approach as something that could help rather than as an established treatment.